en

PRODUCT DETAIL

Irinotecan Kabi 20 mg/ ml koncentrát na infúzny roztok

Code 22793
MA number 44/0472/08-S
Product Form: con inf 1x25 ml/500 mg (liek.inj.skl.hnedá)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Mutual recognition procedure
MAH, country: Fresenius Kabi s.r.o., Czechia
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
L01CE Topoisomerase 1 inhibitors
L01CE02 Irinotecan
Shelf life: 24
Container: brown glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 16.12.2008
SPC: SPC_Irinotecan Kabi 20 mg_ml koncentrát na infúzny roztok_06.2024.pdf  
PIL: PIL_Irinotecan Kabi 20 mg_ml koncentrát na infúzny roztok_06.2024.pdf  
Safety feature Yes
Data update: 07.06.2024
eu-flag.png sk-flag.png